Mineralocorticoid Activity of 19-Hydroxyaldosterone, 19-Nor-Aldosterone, and 3β-Hydroxy-Δ5-Aldosterone: Relative Potencies Measured in Two Bioassay Systems*
- 1 June 1986
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 118 (6) , 2505-2509
- https://doi.org/10.1210/endo-118-6-2505
Abstract
The mineralocorticoid (MC) activities of 19-hydroxyaldosterone (19-OH-Aldo) and 19-nor-aldosterone (19-nor-Aldo) were tested in adrenalectomized male rats. Potency was assessed by three criteria. Overall MC activity is expressed as the ability to decrease the urinary Na+ to K+ ratio; antinatriuretic activity is represented by decreases in the urinary Na+ to creatinine ratio, and kaliuretic activity by increases in the K+ to creatinine ratio. All measurements were made on urine collected 1-3 h postinjection. In this assay, 19-OH-Aldo was 1/100th to 1/140th as active as Aldo, and 19-nor-Aldo possessed MC activity similar to that of Aldo; both steroids possessed antinatriuretic and kaliuretic activities. In contrast, when assayed in vitro in the isolated toad urinary bladder, the natriferic responses of both 19-OH-Aldo and 19-nor-Aldo (10-8, 10-7, and 10-6 M) were not significantly different from those caused by equivalent concentrations of Aldo. 3.beta.-Hydroxy-.delta.5-Aldo is active as a MC in the adrenalectomized male rat, being 1/20th to 1/35th as active as Aldo, but, in contrast to 19-OH-Aldo, was less active in the isolated toad bladder system. 19-OH-Aldo, 19-nor-Aldo, and 3.beta.-hydroxy-.DELTA.5-Aldo could represent important new classes of Aldo analogs.This publication has 12 references indexed in Scilit:
- 19-Nor-Deoxycorticosterone Excretion in Primary Aldosteronism and Low Renin Hypertension*Journal of Clinical Endocrinology & Metabolism, 1983
- Urinary 19-Nor-Deoxycorticosterone Excretion in the Spontaneously Hypertensive Rat*Endocrinology, 1982
- Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized ratAmerican Journal of Physiology-Endocrinology and Metabolism, 1982
- Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in toad bladderAmerican Journal of Physiology-Endocrinology and Metabolism, 1981
- Mineralocorticoid and Hypertensive Effects of 19-Nor-Progesterone*Endocrinology, 1981
- 19-NOR PROGESTERONE IS A MINERALOCORTICOID AGONISTEndocrinology, 1981
- 19-Nor Analogs of Adrenal Steroids: Mineralocorticoid and Glucocorticoid Receptor Activity*Endocrinology, 1980
- Identification of 19-hydroxydeoxycorticosterone in regenerating rat adrenal incubationsSteroids, 1980
- 19-Nor-Deoxycorticosterone: A Potent Mineralcocorticoid Isolated from the Urine of Rats with Regenerating Adrenals*Endocrinology, 1979
- 19-NOR DEOXYCORTKOSTERONE (19-nor DOC): MINERALOCORTICOID RECEPTOR AFFINITY HIGHER THAN ALDOSTERONE, ELECTROLYTE ACTIVITY LOWER.+Endocrinology, 1978